Companhia de Saneamento Basico do Estado de Sao Paulo. ADR (NYSE: SBS)’s stock price has soared by 2.67 in relation to previous closing price of 18.71. Nevertheless, the company has seen a gain of 3.50% in its stock price over the last five trading days. accessnewswire.com reported 2025-04-17 that Crofelemer, a novel plant-based anti-secretory prescription drug, has been granted Orphan Drug Designation by the FDA and the European Medicines Agency (EMA) for both short bowel syndrome (SBS) and microvillus inclusion disease (MVID) and is being evaluated to serve as a potential therapeutic option to manage intestinal failure in these patients There are currently no approved drug treatments for MVID, an ultrarare pediatric disease characterized by severe diarrhea and malabsorption that requires intensive parenteral support for nutritional and fluid management Proof-of-concept data in MVID from this study would provide support for crofelemer’s potential inclusion in the EMA’s PRIME program for novel medicines targeting unmet medical needs and the FDA’s Breakthrough Therapies program SAN FRANCISCO, CA / ACCESS Newswire / April 17, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) family companies Napo Pharmaceuticals (Napo) and Napo Therapeutics today announced that preliminary results from the ongoing pediatric investigator-initiated trial (IIT) of a novel liquid formulation of crofelemer, Jaguar’s novel plant-based anti-secretory prescription drug, for various congenital diarrheal disorders (CDD), including MVID and SBS with intestinal failure (SBS-IF), will be presented by Dr. Mohamad Miqdady at the April 24-26, 2025 Annual ELITE PED-GI Congress in Abu Dhabi in the United Arab Emirates. MVID and SBS-IF, rare orphan diseases requiring intensive parenteral nutrition and support, have severe morbidity and mortality implications and impact the quality of life of both patients and their caregivers.
Is It Worth Investing in Companhia de Saneamento Basico do Estado de Sao Paulo. ADR (NYSE: SBS) Right Now?
The price-to-earnings ratio for Companhia de Saneamento Basico do Estado de Sao Paulo. ADR (NYSE: SBS) is above average at 7.52x, Company’s 36-month beta value is 0.76.Analysts have differing opinions on the stock, with 3 analysts rating it as a “buy,” 3 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for SBS is 683.42M, and currently, short sellers hold a 0.45% ratio of that floaft. The average trading volume of SBS on April 23, 2025 was 1.00M shares.
SBS’s Market Performance
SBS stock saw an increase of 3.50% in the past week, with a monthly gain of 8.78% and a quarterly increase of 22.05%. The volatility ratio for the week is 2.29%, and the volatility levels for the last 30 days are 2.63% for Companhia de Saneamento Basico do Estado de Sao Paulo. ADR (SBS).. The simple moving average for the past 20 days is 6.42% for SBS’s stock, with a 17.31% simple moving average for the past 200 days.
SBS Trading at 10.54% from the 50-Day Moving Average
After a stumble in the market that brought SBS to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 1.40% of gains for the given period.
Volatility was left at 2.63%, however, over the last 30 days, the volatility rate increased by 2.29%, as shares surge +11.56% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +16.21% upper at present.
During the last 5 trading sessions, SBS rose by +3.50%, which changed the moving average for the period of 200-days by +33.96% in comparison to the 20-day moving average, which settled at $18.05. In addition, Companhia de Saneamento Basico do Estado de Sao Paulo. ADR saw 34.05% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for SBS
Current profitability levels for the company are sitting at:
- 0.43 for the present operating margin
- 0.54 for the gross margin
The net margin for Companhia de Saneamento Basico do Estado de Sao Paulo. ADR stands at 0.27. The total capital return value is set at 0.22. Equity return is now at value 28.81, with 13.27 for asset returns.
Based on Companhia de Saneamento Basico do Estado de Sao Paulo. ADR (SBS), the company’s capital structure generated 0.41 points at debt to capital in total, while cash flow to debt ratio is standing at 0.29. The debt to equity ratio resting at 0.68. The interest coverage ratio of the stock is 37.31.
Currently, EBITDA for the company is 8.96 billion with net debt to EBITDA at 1.3. When we switch over and look at the enterprise to sales, we see a ratio of 2.73. The receivables turnover for the company is 9.0for trailing twelve months and the total asset turnover is 0.45. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.89.
Conclusion
In a nutshell, Companhia de Saneamento Basico do Estado de Sao Paulo. ADR (SBS) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
